Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News16 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News18 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General15 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General22 hours agoOne person dead after house fire in Melbourne’s south-east